R4SCQ0 (R4SCQ0_HUMAN) Homo sapiens (Human)
hypoxia-inducible factor-proline dioxygenase UniProtKBInterProInteractive Modelling
426 aa; Sequence (Fasta) ;
1 identical sequence: Homo sapiens: Q9GZT9
Available Structures
55 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| HIF prolyl hydroxylase 2 (PHD2/EGLN1) in complex with 6-(5-oxo-4-(1H- 1,2,3-triazol-1-yl)-2,5-dihyd… |
Heteromer Q9GZT9; | 100.0 | 6×MN; 6×R8J; | |||
| PHD2:Mn:NOG:HIF1-alpha substrate complex |
Heteromer Q16665; Q9GZT9; | 99.56 | 1×MN; 1×OGA; | |||
| HIF PROLYL HYDROXYLASE 2 (PHD2/EGLN1) IN COMPLEX WITH N-OXALYLGLYCINE (NOG) AND HIF-2 ALPHA CODD (5… |
Heteromer Q99814; Q9GZT9; | 100 | 1×MN; 1×OGA; 3×PEG; 1×GOL; 3×FMT; 1×CL; 3×MG; | |||
| HIF PROLYL HYDROXYLASE 2 (PHD2/ EGLN1) in complex with N-Oxalyl Glycine (NOG), HIF-1ALPHA CODD (556… |
Heteromer Q16665; Q9GZT9; | 100 | 1×MN; 1×OGA; 1×GOL; 1×SO4; | |||
| HIF PROLYL HYDROXYLASE 2 (PHD2/ EGLN1) IN COMPLEX WITH 2-OXOGLUTARATE (2OG) AND HIF-1ALPHA CODD (55… |
Heteromer Q16665; Q9GZT9; | 99.1 | 1×MN; 1×AKG; | |||
| HIF PROLYL HYDROXYLASE 2 (PHD2/EGLN1) IN COMPLEX WITH 2-OXOGLUTARATE (2OG) AND HIF-2 ALPHA CODD (52… |
Heteromer Q99814; Q9GZT9; | 100 | 1×MN; 1×AKG; 1×PEG; 11×FMT; 1×GOL; 3×MG; 3×CL; | |||
| Anaerobic crystal structure of HIF prolyl hydroxylase 2 (PHD2 181-407) in complex with HIF2alpha-CO… |
Heteromer Q99814; Q9GZT9; | 100 | 1×FE; 1×AKG; | |||
| Crystal structure of hydroxylated HIF2alpha-CODD peptide (523-542) bound to apo-HIF prolyl hydroxyl… |
Heteromer Q99814; Q9GZT9; | 100 | 4×ACT; | |||
| Aerobic crystal structure of HIF prolyl hydroxylase 2 (PHD2 181-407) in complex with Fe(III), 2-oxo… |
Heteromer Q99814; Q9GZT9; | 100 | 3×MG; 2×CL; 1×FE; 1×AKG; | |||
| Anaerobic crystal structure of apo-HIF prolyl hydroxylase 2 (PHD2 181-407)in complex with acetate (… |
Heteromer Q99814; Q9GZT9; | 100 | 3×ACT; | |||
| Structure of PHD2 in complex with HIF2a-CODD |
Heteromer Q99814; Q9GZT9; | 100 | 1×OGA; 1×GOL; 1×FE; | |||
| HIF prolyl hydroxylase 2 (PHD2-R281C/P317C) cross-linked to HIF-1alpha NODD-L397C/D412C and N-oxaly… |
Heteromer Q16665; Q9GZT9; | 98.14 | 1×MN; 1×OGA; | |||
| HIF prolyl hydroxylase 2 (PHD2-R281C/P317C/R396T) cross-linked to HIF-1alpha NODD-L397C/D412C and N… |
Heteromer Q16665; Q9GZT9; | 97.67 | 2×MN; 2×OGA; | |||
| PHD2:Fe:UN9:partial HIF1-alpha substrate complex |
Heteromer Q16665; Q9GZT9; | 100 | 1×FE2; 1×UN9; | |||
| HIF prolyl hydroxylase 2 (PHD2-R281C/V314C) cross-linked to HIF-1alpha NODD-L397C/D412C and N-oxaly… |
Heteromer Q16665; Q9GZT9; | 98.05 | 1×MN; 1×OGA; 1×SO4; | |||
| HIF prolyl hydroxylase 2 (PHD2/EGLN1) R396T variant in complex with Mn(II) and N-[(1-chloro-4-hydro… | homo-3-mer | 99.56 | 3×MN; 3×UN9; 3×BCT; | |||
| Crystal Structure of Hypoxia-Inducible Factor Prolyl Hydroxylase (PHD2) with (S)-{2-[2-(5-Cyano-3-h… | monomer | 99.57 | 1×1QA; 1×FE2; 3×SO4; | |||
| PHD2 with 2-Oxoglutarate | monomer | 100.0 | 1×SO4; 1×FE2; 1×AKG; | |||
| HIF prolyl hydroxylase 2 (PHD2/ EGLN1) in complex with bicyclic BB-287 | monomer | 100.0 | 1×MN; 1×2JP; 1×BCT; | |||
| Structure of PHD2 in complex with 1,2,4-Triazolo-[1,5-a]pyridine | monomer | 100.0 | 2×SO4; 1×8UY; 1×FE2; | |||
| HIF prolyl hydroxylase 2 (PHD2/ EGLN1) in complex with bicyclic JLS-367 | monomer | 100.0 | 1×MN; 1×PW8; 1×BCT; | |||
| Crystal structure of HIF prolyl hydroxylase EGLN-1 in complex with a biologically active inhibitor | monomer | 100.0 | 1×FE2; 1×UN9; | |||
| HIF prolyl hydroxylase 2 (PHD2/EGLN1) I280V/R281L/I292V variant in complex with Mn(II) and N-[(1-ch… | monomer | 98.65 | 1×MN; 1×CL; 1×UN9; 2×SO4; 2×GOL; 1×BCT; | |||
| HIF prolyl hydroxylase 2 (PHD2/ EGLN1) in complex with monocyclic BB-328 | monomer | 100.0 | 1×FE; 1×PW5; 1×GOL; | |||
| Lysine-N,N-Dimethylated HIF prolyl hydroxylase 2 (PHD2/ EGLN1) in complex with BB-287 | monomer | 100.0 | 1×FE; 1×2JP; 1×BCT; | |||
| HIF prolyl hydroxylase 2 (PHD2/ EGLN1) in complex with CCT6, a GSK1278863-related compound | monomer | 100.0 | 1×MN; 1×B2E; 1×BCT; | |||
| HIF prolyl hydroxylase 2 (PHD2/ EGLN1) in complex with Fe(II) and N-[(1-chloro-4-hydroxyisoquinolin… | monomer | 100.0 | 1×FE2; 1×FNT; | |||
| HIF prolyl hydroxylase 2 (PHD2/EGLN1) G294E variant in complex with Mn(II) and N-[(1-chloro-4-hydro… | monomer | 99.55 | 1×MN; 1×UN9; 1×BCT; | |||
| HIF prolyl hydroxylase 2 (PHD2/EGLN1) K293K/G294E variant in complex with Mn(II) and N-[(1-chloro-4… | monomer | 99.11 | 1×MN; 1×UN9; 2×SO4; 1×BCT; | |||
| Crystal structure of HIF prolyl hydroxylase EGLN-1 in complex with a biologically active inhibitor | monomer | 100.0 | 1×FE2; 1×UN9; | |||
| HIF prolyl hydroxylase 2 (PHD2/ EGLN1) in complex with Vadadustat | monomer | 100.0 | 1×MN; 1×A1Z; 2×SO4; 2×GOL; | |||
| HIF prolyl hydroxylase 2 (PHD2/EGLN1) R371H variant in complex with Mn(II) and N-[(1-chloro-4-hydro… | monomer | 99.55 | 1×MN; 1×UN9; 1×SO4; 1×GOL; | |||
| HIF prolyl hydroxylase 2 (PHD2/EGLN1) P317R variant in complex with Mn(II) and N-[(1-chloro-4-hydro… | monomer | 99.55 | 1×MN; 1×UN9; 1×GOL; 1×BCT; | |||
| HIF prolyl hydroxylase 2 (PHD2/ EGLN1) D315E VARIANT in complex with Mn(II) and N-[(1-chloro-4-hydr… | monomer | 99.55 | 1×MN; 1×UN9; | |||
| HIF prolyl hydroxylase 2 (PHD2/ EGLN1) in complex with bicyclic FG2216 and RaPID-derived cyclic pep… | monomer | 100.0 | 1×MN; 1×UN9; | |||
| HIF prolyl hydroxylase 2 (PHD2/ EGLN1) in complex with a Spiro[4.5]decanone inhibitor (JPHM-2-167) | monomer | 100.0 | 1×MN; 1×J2H; 1×GOL; 1×IPA; 2×SO4; | |||
| HIF prolyl hydroxylase 2 (PHD2/ EGLN1) in complex with N-oxalylglycine (NOG) and a RaPID-derived si… | monomer | 99.05 | 1×MN; 1×OGA; 2×SO4; | |||
| HIF Prolyl Hydroxylase 2 (PHD2/EGLN1) in Complex with 1-(6-morpholinopyrimidin-4-yl)-4-(1H-1,2,3-tr… | monomer | 100.0 | 1×MN; 1×QEQ; 3×CL; | |||
| HIF prolyl hydroxylase 2 (PHD2/ EGLN1) in complex with N-oxalylglycine (NOG) | monomer | 99.09 | 1×MN; 2×OGA; 1×PG4; 3×SO4; 1×GOL; | |||
| HIF prolyl hydroxylase 2 (PHD2/ EGLN1) in complex with 2OG and RaPID-derived silent allosteric cycl… | monomer | 100.0 | 1×MN; 1×AKG; 1×BCT; | |||
| HIF Prolyl Hydroxylase 2 (PHD2/EGLN1) in complex with tert-butyl 6-(5-hydroxy-4-(1H-1,2,3-triazol-1… | monomer | 100.0 | 1×QEE; 1×MN; | |||
| co-crystal structure of non-carboxylic acid inhibitor with PHD2 | monomer | 100.0 | 1×SY6; 1×MN; | |||
| HIF prolyl hydroxylase 2 (PHD2/ EGLN1) in complex with Mn(II) and N-[(1-chloro-4-hydroxyisoquinolin… | monomer | 100 | 1×MN; 1×UN9; | |||
| HIF prolyl hydroxylase 2 (PHD2/ EGLN1) in complex with 4-hydroxy-N-(4-phenoxybenzyl)-2-(1H-pyrazol-… | monomer | 100.0 | 1×LUW; 1×FMT; 1×MN; | |||
| HIF prolyl hydroxylase 2 (PHD2/ EGLN1) in complex with MD-253 | monomer | 100.0 | 1×MN; 1×PW2; | |||
| Cellular Oxygen Sensing: Crystal Structure of Hypoxia-Inducible Factor Prolyl Hydroxylase (PHD2) | monomer | 100 | 1×FE2; 1×4HG; | |||
| HIF prolyl hydroxylase 2 (PHD2/ EGLN1) in complex with Mn(II) and 2-(4-hydroxy-2-oxo-1,2-dihydroqui… | monomer | 100 | 1×MN; 1×QNM; | |||
| CRYSTAL STRUCTURE OF PHD2 CATALYTIC DOMAIN (CID 7465) IN COMPLEX WITH AKB-6548 AT 1.8 A RESOLUTION | monomer | 99.07 | 1×FE2; 1×A1Z; 1×EDO; | |||
| S-nitrosylated PHD2 (GSNO soaked) in complex with Zn(II) and UN9 | monomer | 100 | 1×ZN; 1×UN9; | |||
| S-nitrosylated PHD2 (NO exposed) in complex with Fe(II) and UN9 | monomer | 100 | 1×FE2; 2×UN9; | |||
| Cellular Oxygen Sensing: Crystal Structure of Hypoxia-Inducible Factor Prolyl Hydroxylase (PHD2) | monomer | 100.0 | 1×FE2; 1×4HG; | |||
| PHD2-R127 with JNJ41536014 | monomer | 100.0 | 1×FE2; 1×SO4; 1×014; | |||
| Structure of Prolyl Hydroxylase Domain-containing Protein (PHD) with Inhibitors | monomer | 100.0 | 1×NI; 1×4JR; 1×EDO; | |||
| Hypoxia-Inducible Factor (HIF) Prolyl Hydroxylase 2 (PHD2) in Complex with the Carboxamide Analog J… | monomer | 100.0 | 1×FE2; 1×KU1; | |||
| PHD2-R717 with 40787422 | monomer | 100.0 | 2×ACT; 1×FE2; 2×42Z; 1×PEG; | |||
2 SWISS-MODEL models
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 5ox6.1.A | monomer | 0.85 | 1×MN; 1×A1Z; | 100.00 | ||
| 6cby.2.A | monomer | 0.57 | 1×ZN; | 41.30 | ||